Terazosin HCl dihydrate - Bio-X ™

CAS: 70024-40-7

Ref. 3D-BT164459

Informação sobre produto

• Nome: Terazosin HCl dihydrate - Bio-X ™
• Sinónimos: AdecurApo-TerazosinDefloxDysalfaFlotrin, 1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-((Tetrahydro-2- Furanyl)Carbonyl)-, 1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-(Tetrahydro-2-Furanyl-)Carbonyl)-Piperazine Hydrochloride Dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)pipera zine, Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2), Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, dihydrate, Prestwick0_000751, Prestwick1_000751, SPBio_002701, Smr000058309, Terazosin HCl, Terazosin Hydrochloride Dihydrate, Terazosin monohydrochloride dihydrate, [4-(4-Amino-6,7-Dimethoxy-Quinazolin-2-Yl)Piperazin-1-Yl]-(Oxolan-2-Yl)Methanone, [4-(4-Amino-6,7-Dimethoxyquinazolin-2-Yl)Piperazin-1-Yl](Tetrahydrofuran-2-Yl)Methanone Hydrochloride Dihydrate

Descrição

As an inhibitor of alpha-1 adrenergic receptors, Terazosin causes vasodilation followed by a reduction in urethral resistance, venous return to the heart and peripheral vascular resistance. In particular Terazosin's ability to recover urine flow and alleviate symptoms in patients with benign prostatic hyperplasia is of benefit to the therapeutic and clinical industries.

Terazosin HCL dehydrate is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 459.92 g/mol
• Fórmula: C₁₉H₂₅N₅O₄·ClH·2H₂O
• Pureza: (%) Min. 95%
• Cor/forma: Powder